Compare LMAT & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMAT | HUN |
|---|---|---|
| Founded | 1983 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.8B |
| IPO Year | 2006 | 2004 |
| Metric | LMAT | HUN |
|---|---|---|
| Price | $94.30 | $11.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 11 |
| Target Price | ★ $105.80 | $12.09 |
| AVG Volume (30 Days) | 292.9K | ★ 6.1M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | 0.93% | ★ 2.64% |
| EPS Growth | ★ 30.57 | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | $249,602,000.00 | ★ $5,683,000,000.00 |
| Revenue This Year | $14.21 | $3.08 |
| Revenue Next Year | $8.88 | $5.27 |
| P/E Ratio | $138.13 | ★ N/A |
| Revenue Growth | ★ 13.53 | N/A |
| 52 Week Low | $79.01 | $7.30 |
| 52 Week High | $118.01 | $16.09 |
| Indicator | LMAT | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 30.16 |
| Support Level | $82.26 | $11.16 |
| Resistance Level | $97.83 | $14.12 |
| Average True Range (ATR) | 3.02 | 0.75 |
| MACD | 0.63 | -0.38 |
| Stochastic Oscillator | 61.26 | 6.63 |
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.